Bank of Nova Scotia Trust’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,075
Closed -$247K 139
2024
Q3
$247K Hold
2,075
0.03% 127
2024
Q2
$296K Hold
2,075
0.03% 112
2024
Q1
$266K Sell
2,075
-1,355
-40% -$161K 0.03% 120
2023
Q4
$355K Hold
3,430
0.04% 107
2023
Q3
$312K Sell
3,430
-832
-20% -$73.3K 0.04% 114
2023
Q2
$345K Sell
4,262
-1,460
-26% -$119K 0.04% 111
2023
Q1
$455K Hold
5,722
0.05% 101
2022
Q4
$387K Sell
5,722
-664
-10% -$38.9K 0.04% 107
2022
Q3
$319K Buy
6,386
+72
+1% +$3.86K 0.04% 110
2022
Q2
$352K Sell
6,314
-6
-0.1% -$333 0.04% 109
2022
Q1
$351K Sell
6,320
-2
-0% -$103 0.03% 115
2021
Q4
$354K Sell
6,322
-528
-8% -$28.6K 0.03% 110
2021
Q3
$329K Sell
6,850
-8,000
-54% -$387K 0.03% 107
2021
Q2
$622K Sell
14,850
-298
-2% -$11.6K 0.05% 91
2021
Q1
$511K Buy
15,148
+2
+0% +$71 0.05% 93
2020
Q4
$529K Buy
15,146
+7,022
+86% +$243K 0.06% 90
2020
Q3
$282K Buy
8,124
+14
+0.2% +$467 0.03% 99
2020
Q2
$266K Hold
8,110
0.04% 91
2020
Q1
$244K Hold
8,110
0.04% 93
2019
Q4
$235K Sell
8,110
-478
-6% -$13.2K 0.03% 105
2019
Q3
$222K Buy
8,588
+16
+0.2% +$405 0.03% 107
2019
Q2
$219K Hold
8,572
0.03% 114
2019
Q1
$224K Buy
+8,572
New +$211K 0.03% 111
2017
Q4
Sell
-2,314
Closed -$55K 300
2017
Q3
$55K Buy
+2,314
New +$52.3K 0.01% 240

Other funds holding NVO

Bank of Nova Scotia Trust's NVO Position: Q4 2024 in Review

Bank of Nova Scotia Trust sold out of Novo Nordisk (NVO) in Q4 2024, closing a stake of 2,075 shares — an estimated $247K sold.

Bank of Nova Scotia Trust first reported a position in NVO in Q3 2017 and held it in 24 quarters. The position peaked at $622K in Q2 2021. 1,664 funds tracked by Wall St. Rank hold NVO as of Q4 2024.

  • Bank of Nova Scotia Trust reported no remaining Novo Nordisk position as of Q4 2024 after selling out during the quarter.
  • Bank of Nova Scotia Trust sold 2,075 Novo Nordisk shares in Q4 2024, an estimated $247K.
  • Bank of Nova Scotia Trust first reported a position in Novo Nordisk in Q3 2017 and held it in 24 quarters.
  • Bank of Nova Scotia Trust's Novo Nordisk position peaked at $622K in Q2 2021.
  • 1,664 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2024.

Based on Bank of Nova Scotia Trust's 13F filing for Q4 2024, filed 13 Feb 2025.